Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma

BACKGROUND: Adult T-cell leukemia lymphoma (ATLL) is a chemotherapy-resistant malignancy with a median survival of less than one year that will afflict between one hundred thousand and one million individuals worldwide who are currently infected with human T-cell leukemia virus type 1. Recurrent som...

Descripción completa

Detalles Bibliográficos
Autores principales: Rauch, Daniel A., Olson, Sydney L., Harding, John C., Sundaramoorthi, Hemalatha, Kim, Youngsoo, Zhou, Tianyuan, MacLeod, A. Robert, Challen, Grant, Ratner, Lee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456374/
https://www.ncbi.nlm.nih.gov/pubmed/32859220
http://dx.doi.org/10.1186/s12977-020-00535-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456374/
https://www.ncbi.nlm.nih.gov/pubmed/32859220
http://dx.doi.org/10.1186/s12977-020-00535-z

Ejemplares similares